TENET HEALTHCARE CORP (THC) Stock Earnings & Estimates
USA - NYSE:THC - US88033G4073 - Common Stock
199.76 USD
-3.24 (-1.6%)
199.76 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 19.174B -1.60% | 20.548B 7.17% | 20.665B 0.57% | 21.344B 3.29% | 22.257B 4.28% | 23.368B 4.99% | 23.635B 1.14% | 24.544B 3.85% | 25.432B 3.62% | 26.479B 4.12% | 27.583B 4.17% | |
| EBITDA YoY % growth | 3.128B 1.79% | 3.666B 17.20% | 4.034B 10.04% | 4.516B 11.95% | 4.633B 2.59% | 4.857B 4.83% | 4.713B -2.96% | 4.887B 3.69% | 5.116B 4.69% | 5.35B 4.57% | 5.598B 4.64% | |
| EBIT YoY % growth | 2.287B 3.11% | 2.796B 22.26% | 3.216B 15.02% | 3.698B 14.99% | 3.776B 2.11% | 3.925B 3.95% | 3.851B -1.89% | 4.035B 4.78% | 4.239B 5.06% | 4.448B 4.93% | 4.668B 4.95% | |
| Operating Margin | 11.93% | 13.61% | 15.56% | 17.33% | 16.97% | 16.80% | 16.29% | 16.44% | 16.67% | 16.80% | 16.92% | |
| EPS YoY % growth | 6.83 -9.89% | 6.98 2.20% | 11.90 70.49% | 15.82 32.90% | 16.26 2.83% | 17.87 9.88% | 18.88 5.67% | 21.38 13.24% | 19.09 -10.72% | 21.55 12.91% | 25.06 16.26% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 3.32 13.29% | 4.05 17.69% | 4.36 0.07% | 3.82 -4.89% | 3.55 6.88% | 4.20 3.84% | 4.68 7.18% | 3.86 1.01% | 3.79 6.82% | 4.51 7.29% |
| Revenue Q2Q % growth | 5.302B 3.51% | 5.43B 7.06% | 5.47B 4.73% | 5.512B 4.57% | 5.529B 4.28% | 5.659B 4.22% | 5.8B 6.03% | 5.777B 4.81% | 5.805B 4.99% | 5.991B 5.87% |
| EBITDA Q2Q % growth | 1.045B -24.82% | 1.165B -29.73% | 1.183B -0.92% | 1.135B -15.36% | 1.087B 4.02% | 1.222B 4.89% | 1.243B 5.07% | 1.172B 3.26% | 1.149B 5.70% | 1.289B 5.48% |
| EBIT Q2Q % growth | 838.53M 9.61% | 961.47M 14.46% | 964.62M -2.37% | 915.57M -1.23% | 868.06M 3.52% | 1.008B 4.84% | 1.015B 5.22% | 933.41M 1.95% | 909.44M 4.77% | 1.06B 5.16% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 4.02 74.03% | 2.90 | 1.12 | 38.59% |
| Q1 2025 Q2Q % growth | 4.36 35.40% | 3.16 | 1.20 | 37.79% |
| Q4 2024 Q2Q % growth | 3.44 28.36% | 3.00 | 0.44 | 14.55% |
| Q3 2024 Q2Q % growth | 2.93 103.47% | 2.39 | 0.54 | 22.34% |
| Q2 2024 Q2Q % growth | 2.31 60.42% | 1.92 | 0.39 | 20.57% |
| Q1 2024 Q2Q % growth | 3.22 126.76% | 1.44 | 1.78 | 123.42% |
| Q4 2023 Q2Q % growth | 2.68 36.73% | 1.62 | 1.06 | 65.63% |
| Q3 2023 Q2Q % growth | 1.44 | 1.21 | 0.23 | 19.22% |
| Q2 2023 Q2Q % growth | 1.44 -4.00% | 1.26 | 0.18 | 14.18% |
| Q1 2023 Q2Q % growth | 1.42 -26.42% | 1.17 | 0.25 | 21.67% |
| Q4 2022 Q2Q % growth | 1.96 -27.41% | 1.24 | 0.72 | 58.14% |
| Q3 2022 Q2Q % growth | 1.44 -27.64% | 1.23 | 0.21 | 16.94% |
| Q2 2022 Q2Q % growth | 1.50 -5.66% | 0.80 | 0.70 | 87.33% |
| Q1 2022 Q2Q % growth | 1.93 48.46% | 1.05 | 0.88 | 83.67% |
| Q4 2021 Q2Q % growth | 2.70 -42.80% | 1.51 | 1.19 | 79.27% |
| Q3 2021 Q2Q % growth | 1.99 210.94% | 1.03 | 0.96 | 92.58% |
| Q2 2021 Q2Q % growth | 1.59 26.19% | 1.08 | 0.51 | 47.72% |
| Q1 2021 Q2Q % growth | 1.30 1.56% | 0.73 | 0.57 | 77.68% |
| Q4 2020 Q2Q % growth | 4.72 376.77% | 1.77 | 2.95 | 166.59% |
| Q3 2020 Q2Q % growth | 0.64 10.34% | 0.31 | 0.33 | 103.75% |
| Q2 2020 Q2Q % growth | 1.26 125.00% | -0.72 | 1.98 | 274.68% |
| Q1 2020 Q2Q % growth | 1.28 137.04% | 0.33 | 0.95 | 293.43% |
| Q4 2019 Q2Q % growth | 0.99 | 0.99 | 0.00 | -0.42% |
| Q3 2019 Q2Q % growth | 0.58 | 0.32 | 0.26 | 82.72% |
| Q2 2019 Q2Q % growth | 0.56 | 0.45 | 0.11 | 24.98% |
| Q1 2019 Q2Q % growth | 0.54 | 0.30 | 0.24 | 82.35% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 5.271B 3.29% | 5.212B | 59M | 1.13% |
| Q1 2025 Q2Q % growth | 5.223B -2.70% | 5.193B | 30M | 0.58% |
| Q4 2024 Q2Q % growth | 5.072B -5.71% | 5.221B | -149M | -2.85% |
| Q3 2024 Q2Q % growth | 5.122B 1.11% | 5.103B | 19M | 0.37% |
| Q2 2024 Q2Q % growth | 5.103B 0.41% | 5.053B | 50M | 0.99% |
| Q1 2024 Q2Q % growth | 5.368B 6.91% | 5.204B | 164M | 3.15% |
| Q4 2023 Q2Q % growth | 5.379B 7.80% | 5.346B | 33M | 0.62% |
| Q3 2023 Q2Q % growth | 5.066B 5.52% | 5.074B | -8M | -0.16% |
| Q2 2023 Q2Q % growth | 5.082B 9.57% | 4.957B | 125M | 2.52% |
| Q1 2023 Q2Q % growth | 5.021B 5.82% | 4.892B | 129M | 2.64% |
| Q4 2022 Q2Q % growth | 4.99B 2.76% | 4.988B | 2M | 0.04% |
| Q3 2022 Q2Q % growth | 4.801B -1.90% | 4.862B | -61M | -1.25% |
| Q2 2022 Q2Q % growth | 4.638B -6.38% | 4.827B | -189M | -3.92% |
| Q1 2022 Q2Q % growth | 4.745B -0.75% | 4.752B | -7M | -0.15% |
| Q4 2021 Q2Q % growth | 4.856B -1.20% | 5.055B | -199M | -3.94% |
| Q3 2021 Q2Q % growth | 4.894B 7.40% | 4.855B | 39M | 0.80% |
| Q2 2021 Q2Q % growth | 4.954B 35.80% | 4.839B | 115M | 2.38% |
| Q1 2021 Q2Q % growth | 4.781B 5.77% | 4.814B | -33M | -0.69% |
| Q4 2020 Q2Q % growth | 4.915B 2.27% | 4.934B | -19M | -0.39% |
| Q3 2020 Q2Q % growth | 4.557B -0.24% | 4.447B | 110M | 2.47% |
| Q2 2020 Q2Q % growth | 3.648B -20.00% | 3.798B | -150M | -3.95% |
| Q1 2020 Q2Q % growth | 4.52B -0.55% | 4.674B | -154M | -3.29% |
| Q4 2019 Q2Q % growth | 4.806B | 4.805B | 1M | 0.02% |
| Q3 2019 Q2Q % growth | 4.568B | 4.503B | 65M | 1.44% |
| Q2 2019 Q2Q % growth | 4.56B | 4.524B | 36M | 0.80% |
| Q1 2019 Q2Q % growth | 4.545B | 4.558B | -13M | -0.29% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 28.91% | 0% | 22.16% |
| Revenue | 0% | 1.3% | 0% | 1.03% |